Speakers

Priya Abani

CEO

AliveCor Inc.

Scott Alderucci

Director, Process Development Science

Curia Global

Virginia Amann

Founder

ENTENTE Network

Gbola Amusa

Partner, Chief Scientific Officer

Chardan

Jim Anthony

President

Parexel Biotech

Alex Aravanis

CEO

Moonwalk Biosciences

Anna Barry

Venture Partner

Deerfield

Chris Benko

CEO

Koneksa

Shirley Bergin

Consultant, Advisor & Board Member, Former COO / Executive Producer

TEDMED

Irene Blat

Senior Director, Search and Evaluation for Oncology

Servier Pharmaceuticals

Adam Bluestein

Contributing Writer

Fast Company

Raysa Bousleiman

Senior VP, Life Science & Healthcare Venture Capital Relationships

Silicon Valley Bank

Paul Bresge

CEO

Ray Therapeutics

Rick Bright

CEO/Founder, Bright Global Health

Former BARDA Director

Steve Brozak

President

WBB Securities LLC

Stephen Bruso

Investor

Morning Side Ventures

Jay Campbell

Managing Director, Clinical Accelerator and Venture Fund

Cancer Research Institute

Gabe Cavazos

Senior Managing Director, Investment Banking, Biopharma

Leerink Partners

Akshay Chellappa

Director, Corporate Development

Gilead

Julie Chen

Chief Medical Officer

Human Longevity

Colin Davies

VP, Data Science

TRIPP

Cris De Luca

Partner, Digital

Sanofi Ventures

Allison DeAngelis

Biotech Reporter

STAT News

Daniel Dornbusch

CEO

Excision BioTherapeutics

David Ewing Duncan

Journalist

Author & Researcher

Mark Edwards

CEO & Co-founder

ViewMind

Julie Everett

Chief Business Officer

Eidos Therapeutics Inc., a BridgeBio Company

Stacy Feld

Regional Head, West North America

Johnson & Johnson Innovation

G. Alexander Fleming

Co-Founder & CEO

Kinexum

Cameron Gardner

Director, Research Development

JURA Bio

Andrei Georgescu

CEO

Vivodyne

Chris Ghadban

Chief of Staff

Alix Ventures

Jennifer Goldsack

CEO

Digital Medicine Society (DiMe)

Walter Greenleaf

Visiting Scholar

Stanford Virtual Human Interaction Lab

Kimberly Ha

CEO and Founder

KKH Advisors

Shelley Hartman

CEO

Aegle Therapeutics Corporation

Jim Healy

Managing Partner

Sofinnova Investments

Guy Heathers

Co-Founder & Chief Business Officer

Albatroz Therapeutics

Abraham Heifets

CEO and Co-Founder

Atomwise

Erin Hertzog

Partner

Foley Hoag

Sarah Hill

CEO & Chief Storyteller

Healium

William Ho

Founder, President & CEO

IN8bio

Beth Hoffman

CEO

Origami Therapeutics

Christian Howell

Chief Commercial Officer

Cognito Therapeutics

Tim Hunt

CEO

Alliance for Regenerative Medicine

Stacy Hurt

Patient

..

Nouhad Husseini

SVP, Head of Business Development and Corporate Strategy

Regeneron

Rachelle Jacques

President and CEO

Akari Therapeutics

Ben Johnson

Managing Director, National Head of Early Stage

Silicon Valley Bank

Marc Jones

CEO

Altoida

Maha Katabi

General Partner

Sofinnova Investments

Nikole Kimes

Founder & CEO

Siolta Therapeutics

Tarcan Kiper

CEO

Neo Auvra Corp.

Susan Kirsh

Deputy Undersecretary for Health - Discovery, Education and Affiliate Networks

US Department of Veterans Affairs

Ekaterine Kortkhonjia

Senior Director, Early Innovation Partnering

JnJ Innovation

Mark Kotter

Scientific Founder

clock.bio

Daniel Kraft

Founder & Chair

NextMed Health

Christian Kramme

Chief Scientific Officer

Gameto

Samarth Kulkarni

CEO

CRISPR

Seema Kumar

CEO

Cure

Kyle LaHucik

Senior Reporter

Endpoints News

Andrew Lam

Principal, Special Investments

Ally Bridge Group

Vivian Lee

Managing Director

Aqua Partners LLC

Christine Lemke

Co-Founder and Chief Executive Officer

Evidation Health

Ron Leuty

Senior Reporter

San Francisco Business Times

Angus Liu

Senior Staff Writer

FierceBiotech

Philippe Lopes-Fernandes

Executive VP and CBO

Ipsen

Ted Love

Chairman

Biotechnology Innovation Organization

David Maltz

Managing Partner

Intervalent

Michael Margolis

Senior Managing Director, Co-Head of Healthcare Investment Banking

Oppenheimer & Co

Peter Marks

Director CBER

FDA

Neal Masia

Co-Founder & CEO

EntityRisk

Scott McCarty

Life Science & Healthcare – Southeast, SVB

Silicon Valley Bank

John McDonald

Corporate Vice President, Global Head of Business Development and M&A

Novo Nordisk

Wyatt McDonnell

CEO

Infinimmune, Inc.

Glennis Mehra

Director, BioLabs

NYU Langone

Ricky Mehra

Managing Partner

Continuum Health Ventures

Kenneth Moch

President

Euclidean Life Science Advisors

Martina Molsbergen

CEO

C14 Consulting Group

Julia Moore

Managing Partner

Breakout Ventures

Alex Morgan

Partner

Khosla Ventures

Aziz Mottiwala

CCO

Tarsus Pharmaceuticals

Matthias Müllenbeck

SVP, Head of Global Business Development & Alliance Management

Merck KGaA, Darmstadt, Germany

Michael Notaras

VP, Biotech Public Equities & Venture Capital

Decheng Capital

Crystal Nyitray

CEO

Encellin

Jack O'Meara

CEO

Ochre Bio

Daniel Oliver

CEO

Rejuvenate Bio

Tim Opler

Managing Director, Global Healthcare Group

Stifel

Tom Oxley

CEO and Founder

Synchron

Art Pappas

CEO & Managing General Partner

Pappas Capital

Neel Patel

Executive Managing Director, Head Commercial Advisory Group - Consulting

Syneos Health Consulting

Alex Philippidis

Senior Business Editor

GEN

Jo Jo Platt

President

Platt & Associates

Linda Pullan

Business Development Consultant

Pullan Consulting

Marco Quarta

CEO

Rubedo Life Sciences

John Ramunas

CEO

Rejuvenation Technologies

Nina Rawal

Partner and Co-Head of Ventures

Trill Impact

Beth Rogozinski

CEO

Oncoustics

Jenny Rooke

Managing Partner

Genoa Ventures

Rafael Rosengarten

CEO

Genialis Inc., USA

Alexis Rovner

CEO

64x Bio

Peter Rubin

Executive Director

No Patient Left Behind

Ed Saltzman

Senior Strategic Advisor

Lumanity

Regina Salvat

Principal

Sofinnova Investments

Joel Sandler

Principal

Lumanity

Michael Sarshad

Managing Director, Commercial Advisory Group

Syneos Health

Celestine Schnugg

Managing Director

Boom Capital Management

Bruce Seeley

Owner

BioOncology Consulting

Sapan Shah

CEO

Glyscend Therapeutics

Tracy Shapiro

Partner

Wilson Sonsini

Nigel Sheail

Venture Partner

Versant Ventures

Yoshitsugu Shitaka

Chief Scientific Officer

Astellas

Joe Shonkwiler

COO

Advanced Research Projects Agency for Health (ARPA-H)

Paul Stoffels

CEO & Chairman

Galapagos

David Suendermann-Oeft

CEO

Modality.AI, Inc.

Tari Suprapto

Director, Search and Evaluation

Novo Nordisk

Kurt Thorn

Chief Technology Officer

ArrePath

Issei Tsukamoto

Global Head of Business Development

Astellas

Brent Vaughan

CEO

Cognito Therapeutics

Jane Williams

Vice President, Head of Neuroscience, Rare Disease and Pediatrics

Syneos Health

Mylene Yao

CEO

Univfy

Eva Yin

Partner

Wilson Sonsini

Hanadie Yousef

CEO

Juvena Therapeutics

Ashley Zehnder

Founder and CEO

Fauna Bio